Risa Konishi
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Anti-SAE Antibody-Positive Dermatomyositis Presenting With Widespread Erythema Complicated by Rosai-Dorfman Disease.
Journal: The Journal of dermatology
Published: May 09, 2025
Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 08, 2024
Murine models of idiopathic inflammatory myopathies.
Journal: The Journal of dermatology
Published: January 19, 2024
Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis.
Journal: Immunological medicine
Published: January 04, 2024
A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.
Journal: The Journal of dermatology
Published: July 06, 2023
Murine models of idiopathic inflammatory myopathy.
Journal: Immunological medicine
Published: October 25, 2022
Blockade of CD122 on memory T cells in the skin suppresses sclerodermatous graft-versus-host disease.
Journal: Journal of dermatological science
Published: September 20, 2022
Relevance of leukaemia inhibitory factor to anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease.
Journal: Rheumatology (Oxford, England)
Published: July 30, 2022
The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis.
Journal: The Journal of investigative dermatology
Published: November 23, 2021
Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody.
Journal: Rheumatology advances in practice
Published: October 27, 2021
Clinically amyopathic dermatomyositis with diffuse erosive erythema in a patient with anti-small ubiquitin-like modifier activating enzyme antibody.
Journal: International journal of dermatology
Published: October 07, 2021
Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy.
Journal: Rheumatology (Oxford, England)
Published: September 05, 2021
Last Updated: 09/26/2026